Tralokinumab self-administered by patients with atopic dermatitis via a pre-filled pen is a safe and effective treatment option.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback